A new CRISPR DNA shredder could change gene-editing -- what it means for CRISPR Therapeutics

This new technology could one day significantly expand the market for gene-editing biotechs.
The Motley Fool

CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential

CRISPR Therapeutics has been around for years, but it only recently commercialized its first product. Casgevy is a gene editing treatment co-developed with Vertex Pharmaceuticals to treat sickle cell ...
Los Angeles Times

How CRISPR Works: Unpacking the Science of Cas9 and Gene Modification

CRISPR functions as a programmable genetic memory system derived from bacterial immune defenses against viral infections. Guide RNA allows for rapid multiplexed targeting compared to older ...